Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medifron DBT Co. Ltd.
DescriptionTransient receptor potential vanilloid 1 (TRPV1; VR1) antagonist
Molecular Target Transient receptor potential vanilloid 1 (TRPV1) (VR1)
Mechanism of ActionTransient receptor potential vanilloid 1 (TRPV1) (VR1) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
PartnerGruenenthal Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today